MALAT1 and central nervous system cancer: MALAT-1 knockdown significantly reduced MAPK/ERK signalling in gallbladder cancer cells [110], and in glioma, MALAT-1 acts as a tumour suppressor by attenuating ERK/MAPK mediated signalling [111].